Clinical Trial: Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage Cancer Patients

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07827066) titled 'Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage Cancer Patients' on July 28.

Brief Summary: The goal of this clinical trial is to evaluate the effectiveness of a Multi-Theory Model (MTM)-based AI agent intervention for smoking cessation in early-stage cancer patients (clinical stage cTNM 0~II) who currently smoke. The main questions it aims to answer are:

Does the AI agent intervention improve the biochemically verified 7-day point prevalence abstinence rate at the 6-month follow-up compared to control groups?

Is the AI agent intervention feasible and acceptable for early-stage cancer patients?...